MARKET PROFILE: Mongolia - Pharma’s Final Frontier?
This article was originally published in PharmAsia News
Mongolia is a country with a huge territory but relatively small population. In recent years, the country has developed rapidly because of its massive coking coal and copper deposits, with GDP growth of 7.8% in 2014. But what are the features, prospects and challenges for its healthcare industry?
You may also be interested in...
Pharma’s latest partnerships focus on Duchenne muscular dystrophy with Precision Biosciences, protein degradation with Seed. Bristol and Schrodinger team in computational drug discovery.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.
The UK's Advertising Standards Authority will closely monitor the marketing communications of dietary supplements e-tailer Health Solutions after it failed to provide a substantive response to health claims regulation breaches.